These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9630164)

  • 21. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP.
    Ganea D; Delgado M
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):101-10. PubMed ID: 11348014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
    Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
    J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
    Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.
    Delgado M; Ganea D
    J Neuroimmunol; 2000 Oct; 110(1-2):97-105. PubMed ID: 11024538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility.
    Garrido E; Delgado M; Martínez C; Gomariz RP; De la Fuente M
    Neuropeptides; 1996 Dec; 30(6):583-95. PubMed ID: 9004257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
    Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
    Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.
    Delgado M; Leceta J; Ganea D
    J Leukoc Biol; 2003 Jan; 73(1):155-64. PubMed ID: 12525573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase activating polypeptide (PACAP) and related peptides.
    Ichinose M; Asai M; Imai K; Sawada M
    Immunopharmacology; 1995 Sep; 30(3):217-24. PubMed ID: 8557521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo.
    Delgado M; Ganea D
    Arch Physiol Biochem; 2001 Oct; 109(4):377-82. PubMed ID: 11935377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
    Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary adenylate cyclase-activating polypeptide (PACAP) regulation of sympathetic neuron neuropeptide Y and catecholamine expression.
    May V; Braas KM
    J Neurochem; 1995 Sep; 65(3):978-87. PubMed ID: 7643128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.
    Ganea D
    Adv Neuroimmunol; 1996; 6(1):61-74. PubMed ID: 8790782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extracellular-signal-regulated kinase1/2 pathways.
    Vlotides G; Zitzmann K; Hengge S; Engelhardt D; Stalla GK; Auernhammer CJ
    Endocrinology; 2004 Feb; 145(2):716-27. PubMed ID: 14605001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.